Breast Cancer: Treatment, Outcomes, and Cost-Effectiveness

Abstract

Little is known about the relationships between breast cancer treatments, costs, and outcomes across different population groups, health care delivery settings, and geographic areas. As a result of this uncertainty the cost effectiveness of different patterns of breast cancer prevention and treatment across such groups, appropriate policies for breast cancer are unclear. This research will develop evidence on these issues using a combination of very large, unique databases that integrate longitudinal information on individual treatments, costs, and outcomes and that have been linked to supplementary datasets with far more clinical detail. We will characterize variations and trends across different demographic and socioeconomic groups in all phases of breast cancer screening and treatment. We will investigate variations and trends for different measures of inpatient and outpatient costs, and different measures of patient outcomes. The resulting empirical cost-effectiveness estimates of alternative approaches to breast cancer treatment can be used to evaluate technologies used for breast cancer treatment and to guide policies affecting breast cancer management.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 1997
Accession Number
ADA332430

Entities

People

  • Mark B. Mcclellan

Organizations

  • National Bureau of Economic Research

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Animals
  • Biomedical Research
  • Breast Cancer
  • Classification
  • Deoxyribonucleic Acids
  • Federal Law
  • Information Operations
  • Instructions
  • Laboratory Animals
  • Materials
  • Molecules
  • Neoplasms
  • Recombinant Dna
  • Security
  • Standards

Fields of Study

  • Medicine
  • Political science

Readers

  • Computational Modeling and Simulation
  • Oncology
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.